Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.65
18.09.22
-
18.09.23
-3.77%
01.10.22

Risky Investment
Global_Player 
18.09.22 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.62
13.09.22
-
13.09.23
-37.10%
17.09.22

Could be very worthwhile Investment >20% year
bundfuture 
13.09.22 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.62
14.09.22
-
14.09.23
1.70%
17.09.22

Risky Investment
Vassago1 
14.09.22 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.72
07.08.22
-
07.08.23
-13.98%
26.08.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
07.08.22 0%
buy
Maternus-Kliniken AG

Start price
Target price
Perf. (%)
€4.74
23.12.21
-
23.12.22
-50.21%
25.08.22

systinvest 
23.12.21 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.91
13.08.22
€1.00
13.08.23
-12.70%
23.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Marianka 
13.08.22 60%
sell
Crossject S.A.

Start price
Target price
Perf. (%)
€2.82
18.11.21
€2.50
18.11.22
66.84%
16.08.22

Could be worthwhile Investment >10% per year
melinda 
18.11.21 50%
sell
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.50
26.07.21
-
26.07.22
-74.03%
27.07.22

Probably not worthwhile Investment
Lokrim 
26.07.21 10%
buy
Allied Healthcare Products Inc

Start price
Target price
Perf. (%)
€5.75
14.07.21
-
14.07.22
-68.30%
15.07.22

Could be worthwhile Investment >10% per year
skyrockerZoe 
14.07.21 0%
buy
Alpha Pro Tech Ltd.

Start price
Target price
Perf. (%)
€6.22
11.07.21
€12.00
11.07.22
-30.03%
12.07.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Small cyclical dependencies
Undervalued
AlexKlar 
11.07.21 90%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.24
24.06.22
€5.00
24.06.23
-1.57%
26.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Marianka 
24.06.22 50%
sell
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.77
10.06.22
€0.20
10.06.23
24.58%
26.06.22

Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
dimontalban 
10.06.22 70%
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.87
13.10.21
€10.00
13.10.24
-4.83%
15.06.22

Leading role in innovation
Capable Management
Good culture
Strong uniques
stockpicking 
13.10.21 100%
buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€5.95
02.05.22
€12.00
02.05.23
-25.71%
16.05.22

Could be very worthwhile Investment >20% year
DomRuinart 
02.05.22 50%
buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€5.95
19.04.22
€11.00
19.04.23
0.00%
02.05.22

Could be very worthwhile Investment >20% year
DomRuinart 
19.04.22 50%
buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€6.20
05.04.22
€11.50
05.04.23
-4.03%
19.04.22

Could be very worthwhile Investment >20% year
DomRuinart 
05.04.22 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.16
09.04.22
-
09.04.23
0.00%
18.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
09.04.22 0%
sell
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€6.95
07.04.22
-
07.04.23
-17.99%
14.04.22

Probably not worthwhile Investment
tinelchen 
07.04.22 0%
buy
PAVmed Inc

Start price
Target price
Perf. (%)
€1.35
21.03.22
€8.00
21.03.23
-14.92%
02.04.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
Marianka 
21.03.22 70%
sell
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€8.50
30.03.22
-
30.03.23
-24.12%
31.03.22

Risky Investment
Global_Player 
30.03.22 50%
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.94
12.07.21
-
12.07.22
5.94%
13.03.22

Kilianhammernick 
12.07.21 50%
buy
Spineway

Start price
Target price
Perf. (%)
€68.00
15.06.21
-
15.06.22
-52.94%
16.02.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Heyer1977 
15.06.21 50%
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.86
25.01.21
€1.00
25.01.22
-80.01%
24.01.22

Could be worthwhile Investment >10% per year
melinda 
25.01.21 50%
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€1.85
23.01.21
€60.00
23.01.22
-41.51%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 50%
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.16
23.01.21
€30.00
23.01.22
-67.09%
24.01.22

Could be very worthwhile Investment >20% year
Maxi_Scalibusa 
23.01.21 50%